Common Reasons for Drug Patent Rejections and Solutions
The process of obtaining a patent for a drug invention can be complex and time-consuming. Despite the best efforts of […]
Common Reasons for Drug Patent Rejections and Solutions Read Post »
The process of obtaining a patent for a drug invention can be complex and time-consuming. Despite the best efforts of […]
Common Reasons for Drug Patent Rejections and Solutions Read Post »
I. Introduction In the ever-evolving landscape of pharmaceutical research and development, a revolutionary force is reshaping the way we approach
The Role of Artificial Intelligence (AI) and Machine Learning (ML) in Drug Repurposing Read Post »
The traditional marketing models that once dominated the pharmaceutical industry are rapidly becoming obsolete, paving the way for innovative approaches
Drug repurposing has emerged as a promising strategy to bring new treatments to patients more quickly and cost-effectively. However, navigating
Intellectual Property Rights and Regulatory Considerations for Drug Repurposing Read Post »
Patient centricity has become a crucial aspect of the pharmaceutical industry, particularly in the development of generic drugs. This approach
Unlocking Patient Centricity in Generic Drug Development Read Post »
The global pharmaceutical industry faces a significant challenge in ensuring access to essential medicines, particularly in emerging markets where affordability
Expanding Access to Medicines: The Role of Generics in Emerging Markets Read Post »
The pharmaceutical industry has increasingly turned to contract development and manufacturing organizations (CDMOs) to optimize their facilities and outsource non-core
Setting the right price for a new medicine is both an art and a science. It’s a decision that can
Setting the Correct Medicine Launch Prices: A Comprehensive Guide Read Post »
The pharmaceutical industry is constantly evolving, and one of the most exciting areas of growth is the development of biosimilars.
Navigating the Complex Landscape: Key Challenges in Biosimilar Development Read Post »
Get fresh news and insights, drug patent expirations & more…